Dr. Baharak Moshiree, MD

Dr. Moshiree practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Moshiree's NPI, 1609979715, was assigned on September 6, 2006. Dr. Moshiree graduated from University of Florida College of Medicine in 2000. Dr. Moshiree holds North Carolina license 2017-02542.

Dr. Moshiree's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Moshiree's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Moshiree is also affiliated with Atrium Health Carolinas Rehabilitation. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Moshiree to 1 more hospital, 4 group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Moshiree practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Moshiree's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Moshiree is licensed in North Carolina.

CMS data shows 235 Medicare services from Dr. Moshiree across 8 procedure codes in 2024, for 160 Medicare patients. Medicare paid $16,212 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Moshiree in 2024. The largest group is 65 to 74, with 86 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Moshiree's median patient age at 68, with 74% women.

In 2024, Dr. Moshiree wrote 419 Medicare Part D claims for 127 patients. 58% of them were for generic drugs. CMS names the drug for 239 of them, across 10 drugs with 11 or more claims each, at $108,652 in total drug cost. In 2023, CMS named 181 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Moshiree for performance year 2024, reported as part of a group. Dr. Moshiree accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 62 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Moshiree, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 54 papers to Dr. Moshiree, published from 2010 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Gastroparesis, Constipation and Gastric Emptying. Dr. Moshiree has published most often in Am J Gastroenterol. Dr. Moshiree's most frequent co-authors are Braden Kuo, MD, Allen A. Lee, MD and Henry P. Parkman, MD.

Dmand AI links Dr. Moshiree to 1 clinical trial. Conditions studied include Abdominal Pain and Irritable Bowel Syndrome. Open Payments lists research payments to Dr. Moshiree that name 1 trial.

CMS Open Payments shows 246 general payments to Dr. Moshiree from 34 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 36% of the total. Bausch Health Americas, Inc. paid the most, $57,763. It also lists 1 research payment totaling $70 in 2025, naming 1 clinical trial.

Dr. Moshiree graduated from University of Florida College of Medicine in 2000.